ABSTRACT
Individual populations show a variety of sensitization patterns, which may be associated with the geographic region, climate, dietary habits, or ways of preparing food. The purpose of this study was to comprehensively assess the food allergy sensitization profile in Polish children, particularly to eight food allergens (so-called "the Big 8"): cow milk, eggs, wheat, soybeans, fish, crustacean shellfish, tree nuts, and peanuts. To assess the prevalence and serum levels of specific immunoglobulins E (sIgE), we analyzed the results obtained from selected laboratories located in all regions of Poland that used the multiplex ALEX® test in the period from 2019 to 2022. Results from 3715 children were obtained. The mean age of the study population was 7.0 years. The results were stratified by age: <12 months (3.63%), 1-5 years (39.54%), 6-13 years (46.32%), and 14-18 years (10.0%). The final analysis included the sIgE results obtained with 95 food extracts and 77 food allergen molecules. The highest rates of sIgE to food allergen extracts were found for peanut (29.20%), hazel (28.20%), and apple (23.60%), and those to allergenic molecules were found for the PR-10 family of molecules (Cor a 1.0401 (23.77%), Mal d 1 (22.37%), Ara h 8 (16.93%), and globulin 7/8S (Ara h 1; 15.59%)). The lowest rates of sIgE reactivity to extracts were found for strawberry (0.40%), oregano (0.30%), and thornback ray (0.16%), and those to allergenic molecules were found for Mal d 2 (0.27%) (thaumatin-like protein, TLP), Ani s 1 (0.30%) (Kunitz-type serine protease inhibitor), and Che a 1 (0.43%) (Ole e 1 family). The rates of sensitization to storage proteins of the analyzed "the Big 8" molecules decreased significantly (p < 0.05) with age. Conversely, the rates of sensitization to PR-10 family proteins increased significantly with age. The three most common allergens in Poland, regardless of whether IgE was assayed against extracts or molecules of food allergens, were peanut, hazel, and apple (in different order depending on the ranking). A detailed analysis of sensitization to the extracts and molecules of main food allergens based on the results of a multiplex ALEX® test demonstrated the sensitization profile in Polish children (including molecular sensitization, particularly the "the Big 8" food allergen molecules), which shows considerable differences in comparison with those in other countries. Serum sIgE analysis of children from all regions of Poland revealed a food allergen molecular sensitization profile that changes with age.
Subject(s)
Food Hypersensitivity , Child , Animals , Cattle , Female , Humans , Infant , Poland/epidemiology , Food Hypersensitivity/diagnosis , Food Hypersensitivity/epidemiology , Laboratories , Arachis , Eggs , AllergensABSTRACT
Background and Objectives: Measurement of fractional exhaled nitric oxide (FeNO) concentration is currently used as a non-invasive biomarker to assess airway inflammation. Many factors can influence the FeNO level. However, there have been no reports concerning factors attributed to FeNO levels in different age groups of children, especially those with high FeNO values. Therefore, this study aimed to assess the influence of selected factors on nitric oxide concentration in exhaled air in children aged 8-9 attending class 3 of public primary schools in Krakow with high FeNO values ≥ 20 ppb. Materials and Methods: The population-based study covered all third-grade pupils attending primary schools in the city of Krakow. Five thousand, four hundred and sixty children participated in the first screening stage, conducted from October 2017 to January 2018. Then, 792 participants with an FeNO level ≥ 20 ppb were selected. Finally, those selected pupils were invited to participate in the second stage, diagnostic, in April 2018. Four hundred and fifty-four children completed the diagnostic stage of the study, and their data was included in the presented analysis. Results and Conclusions: Significantly higher FeNO levels were observed in children diagnosed with the following diseases: asthma, allergic rhinitis, atopic dermatitis, and allergy (p < 0.05). In addition, it was observed that a higher FeNO concentration characterised children taking antihistamines compared to children not taking those medications (p = 0.008). In multivariate models, we observed that regardless of sex, age, BMI value, home smoking, and whether they were taking medications, children who had allergic rhinitis, or atopic dermatitis, or allergies had significantly higher FeNO levels. The strongest relationship was noted with allergic diseases. The results of our study may be of importance to clinicians when interpreting FeNO results, for example, when making a therapeutic decision.
Subject(s)
Asthma , Dermatitis, Atopic , Asthma/diagnosis , Asthma/epidemiology , Breath Tests/methods , Child , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/epidemiology , Exhalation , Humans , Nitric Oxide/analysisABSTRACT
BACKGROUND: Substantial discrepancies among anaphylaxis severity scores may delay epinephrine administration. OBJECTIVE: The study aims to develop a transparent severity grading system of food-induced acute allergic reactions with a decision model for epinephrine use. METHODS: The natural course of 315 acute food-induced allergic reactions in children hospitalized at the Allergology department between May 2016 and July 2019 owing to follow-up treatment and allergy diagnostics was evaluated. The severity of episodes was classified according to the 5 most accepted grading systems. The interrater reliability of classification between anaphylaxis severity scores was assessed. All symptoms were grouped into a heat map according to their real-life incidence and clinical relevance. Based on the heat map analysis, a severity grading system of food-induced acute allergic reactions in children with the epinephrine administration decision model was created. RESULTS: Data from 259 food-induced anaphylaxis episodes in 157 children were included in the analysis. Comparing the grading systems, we observed a 24.7% to 70.2% disagreement between severity scores. The heat map illustrated a strong association between 29 symptoms and their categorization. A new severity grading system was developed and a 2-stage decision model was proposed: "epinephrine yes" (any rapidly progressing symptoms, even mild ones or from 1 organ system; any symptoms from more than 1 organ system; or every grade of anaphylaxis), and "epinephrine available and prepared to use" (nonprogressing mild systemic allergic reaction from 1 system area only; no anaphylaxis). CONCLUSION: A new severity grading system of food-induced acute allergic reactions in children could serve as a clinical tool for health care professionals to avoid epinephrine administration delay.
Subject(s)
Decision Support Techniques , Epinephrine/therapeutic use , Food Hypersensitivity/diagnosis , Food Hypersensitivity/drug therapy , Severity of Illness Index , Adolescent , Allergens/immunology , Anaphylaxis/diagnosis , Anaphylaxis/drug therapy , Anaphylaxis/pathology , Child , Child, Preschool , Epinephrine/administration & dosage , Female , Food Hypersensitivity/pathology , Humans , Infant , Infant, Newborn , MaleABSTRACT
In patients having a history of anaphylaxis after consumption of peanuts, sunflower seeds, or soy and skin or blood tests negative for the allergen extracts, oleosins could be the culprit. Oleosins are common and largely underestimated allergy inducers of plant origin, causing severe allergy symptoms, including the anaphylactic shock. They are resistant to high temperatures and digestive enzymes. The consumption of heat-treated oleosins has been associated with a higher risk of a severe anaphylactic reaction. Recent studies have shown that oleosins could be a biomarker of the allergy severity to peanuts. Oleosins have a hydrophobic structure and thus, are poorly soluble in aqueous solutions. The aqueous extraction, separation, and purification procedures do not guarantee their solubility. Oleosins dissolve only in the presence of detergents, which limits their use in both in vivo and in vitro allergy tests. Recently, a multiparameter allergy test that detects the allergen-specific immunoglobulin E (sIgE) against oleosins has become available. This capability may help to unravel the presence of oleosin source during the routine diagnostic of allergy, which is conducive to assessing the risk for severe anaphylaxis and may also help to clarify the ambiguous allergy cases.
Subject(s)
Hypersensitivity , Allergens , Genes, Plant , Humans , Hypersensitivity/diagnosis , Immunoglobulin EABSTRACT
Atopic dermatitis (AD) is characterized by exacerbations and remissions of eczematous skin, underlain by impaired skin barrier and aberrant Th2-type and Th-22 cytokine production. A number of allergens, in particular contact with fur animals, may aggravate the disease. This study seeks to define the influence of having a regular contact with a pet cat at home on the severity of symptoms and signs of AD. We addressed the issue using the SCORing Atopic Dermatitis (SCORAD) and visual analog (VAS) scores to assess the intensity of pruritus and by measuring the blood content of specific IgE and IL-4, IL-13, and IL-22 cytokines. The study group consisted of 47 adult patients suffering from AD since childhood, 18 of whom declared having regular contact with a cat and the remaining 29 who denied it. There also was a control group consisted of 16 healthy volunteers with no AD signs. The SCORAD and VAS scores were significantly higher in patients in contact with a cat than in those without it (median SCORAD 61.0 vs. 50.4 and VAS 9.0 vs. 4.0 points, respectively). The sIgE of a majority of patients (94.4%) in contact with a cat was in Class V-VI, compared with just a few patients (3.4%) with no such contact, having sIgE in the same classes (p < 0.001). Significant correlations were revealed between SCORAD and VAS scores and the class level of serum sIgE value. In addition, IL-22 was a single elevated cytokine, only in the patients in contact with a cat, and it correlated with pruritus severity. The results of the study underline the need to beware of the cat fur allergen, and they stress forethought and caution in acquiring and keeping a pet cat by patients suffering from AD.
Subject(s)
Cats/immunology , Dermatitis, Atopic/immunology , Dermatitis, Atopic/pathology , Adult , Animals , Case-Control Studies , Child , Cytokines/immunology , Dermatitis, Atopic/complications , Eczema/complications , Eczema/pathology , Humans , Pruritus/complications , Pruritus/pathology , Severity of Illness Index , Skin/immunology , Skin/pathologyABSTRACT
BACKGROUND: Food allergy in children can be life-threatening. Component-resolved diagnostics approach to food anaphylaxis is rarely assessed in children. The aim of the study was to identify the food allergen components as the triggers responsible for severe anaphylaxis, with regard to characteristics and associated risks, among children in a large, population-based setting. METHODS: Two hundred and seventy-one children who were hospitalized due to systemic allergic reaction (SAR) and food anaphylaxis were recruited. Medical history was assessed, and culprit allergen source and anaphylaxis severity grade were established. Specific IgE to 112 allergen components using multiplex ImmunoCAP ISAC immunoassay and specific IgE to hazelnut, Cor a 14, and cashew, Ana o 3, using singleplex ImmunoCAP immunoassay were determined. RESULTS: We analyzed data from 237 SAR/anaphylaxis in 237 children. Trigger at allergen component level was defined for every episode. The most common triggers of SAR/anaphylaxis were seeds (50.6%), among them, the storage proteins. Anaphylaxis triggered by Ana o 3, 2S albumin from cashews (aOR = 15.0; 95% CI: 3.27 to 73.47); Tri a 19 from wheat (aOR = 9.93; 95% CI: 1.73 to 56.97); and Cor a 9 from hazelnut (aOR = 6.53; 95% CI: 1.16 to 36.72) had the worst clinical presentation including cardiovascular and severe respiratory symptoms (grade IV-V vs I-III in Cox scale). Thirteen out of 237 (5.5%) SAR/anaphylaxis patients were triggered by Ana o 3. Almost 82% of patients with severe Ana o 3 anaphylaxis were sensitized only to this component and had no concomitant food sensitization. CONCLUSION: Monosensitization to Ana o 3 is, irrespective of other parameters, connected with high risk of severe anaphylaxis.
Subject(s)
Anaphylaxis/diagnosis , Anaphylaxis/immunology , Antigens, Plant/immunology , Food Hypersensitivity/diagnosis , Food Hypersensitivity/immunology , Plant Proteins/immunology , Adolescent , Age Factors , Child , Child, Preschool , Female , Humans , Immunization , Immunoglobulin E/immunology , Incidence , Infant , Infant, Newborn , MaleABSTRACT
Despite being clinically largely irrelevant, antibodies against cross-reactive carbohydrate determinants (CCD) are an important issue in the in vitro diagnostics, as they may produce false positive or falsely elevated results of the immunoglobulin E class (asIgE) in relation to the actually present level of asIgE. The present chapter demonstrates an effective resolution of this diagnostic issue by the use of a CCD inhibitor in in vitro tests. A synthetic CCD inhibitor, Polycheck® CCD inhibitor, was used in the laboratory diagnostics of 24 children diagnosed with allergic diseases. The anti-CCD antibody content was measured in the serum using a Polycheck® Atopic 30-I panel (Biocheck GmbH; Münster, Germany), a screening assay for the quantitative determination of multiple allergen-specific IgE. We found that the baseline anti-CCD antibody content, without the CCD inhibitor, ranged from 0.7 to 3.5 kU/L in the sera of the majority of 16 out of 24 children. When the CCD inhibitor was applied, the anti-CCD antibody content decreased in 16, remained unchanged in 3, and increased in 5 samples. In samples positive for plant allergens, the asIgE content dropped by an average of 72% when the CCD inhibitor was used in the assay, except the antibodies to tree and grass pollen allergens, for which the asIgE content remained above 100 kU/L. We conclude that the use of a CCD inhibitor in in vitro assays is a viable option to mitigate the influence of anti-CCD antibodies on the measured level of asIgE immunoglobulin, which increase the reliability of testing particularly in cases displaying multiple allergies.
Subject(s)
Carbohydrates/immunology , Hypersensitivity/diagnosis , Immunoglobulin E/blood , Allergens/immunology , Child , Humans , Pollen/immunology , Reproducibility of ResultsSubject(s)
Anaphylaxis , Food Hypersensitivity , Anaphylaxis/diagnosis , Anaphylaxis/etiology , Child , Cluster Analysis , Food Hypersensitivity/diagnosis , Humans , PhenotypeABSTRACT
The consequences of air pollution pose one of the most serious threats to human health, and especially impact children from large agglomerations. The measurement of nitric oxide concentration in exhaled air (FeNO) is a valuable biomarker in detecting and monitoring airway inflammation. However, only a few studies have assessed the relationship between FeNO and the level of air pollution. The study aims to estimate the concentration of FeNO in the population of children aged 8-9 attending the third grade of public primary schools in Krakow, as well as to determine the relationship between FeNO concentration and dust and gaseous air pollutants. The research included 4580 children aged 8-9 years who had two FeNO measurements in the winter-autumn and spring-summer periods. The degree of air pollution was obtained from the Regional Inspectorate of Environmental Protection in Krakow. The concentration of pollutants was obtained from three measurement stations located in different parts of the city. The FeNO results were related to air pollution parameters. The study showed weak but significant relationships between FeNO and air pollution parameters. The most significant positive correlations were found for CO8h (r = 0.1491, p < 0.001), C6H6 (r = 0.1420, p < 0.001), PM10 (r = 0.1054, p < 0.001) and PM2.5 (r = 0.1112, p < 0.001). We suggest that particulate and gaseous air pollutants impact FeNO concentration in children aged 8-9 years. More research is needed to assess the impact of air pollution on FeNO concentration in children. The results of such studies could help to explain the increase in the number of allergic and respiratory diseases seen in children in recent decades.
Subject(s)
Air Pollutants , Air Pollution , Air Pollutants/adverse effects , Air Pollutants/analysis , Air Pollution/adverse effects , Air Pollution/analysis , Child , Environmental Exposure/analysis , Humans , Nitric Oxide/analysis , Particulate Matter/analysis , SchoolsABSTRACT
INTRODUCTION: COPD is one of the most important lung diseases. It is responsible for significant proportion of outpatients pulmonary clinics visits. Data on outpatients care of COPD patients in Poland are limited. This article presents design of the KOMPAS study and basic results relating to COPD patients. MATERIAL AND METHODS: The aim of this prospective study was to describe population of patients with COPD treated by specialists, and to characterize methods of care used in various COPD stages. Participating physicians used pocket PCs equipped with specially developed software to collect COPD patients' data. RESULTS: Data on 2958 COPD patients were analyzed. 2/3 of patients were males. Mean patients age was 63 years and mean FEV(1) - 57% of predicted value. 86% of all subjects underwent spirometry during the first visit or the previous 6 months. Cough and exertional dyspnoea were the most frequently reported COPD symptoms (about 80% of patients). At the first visit 32% of subjects were current smokers and 51% were ex-smokers. 17% of all study patients have never smoked. Before inclusion 2/3 of patients were treated with bronchodilatator, and about 1/3 with inhaled steroid. After entering the study, over 90% received bronchodilatator and more than 2/3 received inhaled steroid. Differences in treatment between stages of COPD based on its severity were relatively small. CONCLUSIONS: Results of the KOMPAS study provide basic information about COPD outpatients care in Poland. These data, especially concerning physicians' compliance with current COPD guidelines, may be useful in planning undergraduate/postgraduate training for physicians and for those who are responsible for health resource allocation.
Subject(s)
Ambulatory Care/methods , Medicine/classification , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/therapy , Pulmonary Medicine/methods , Age Distribution , Bronchodilator Agents/therapeutic use , Comorbidity , Data Collection , Female , Forced Expiratory Volume , Humans , Male , Medicine/statistics & numerical data , Middle Aged , Poland , Predictive Value of Tests , Prospective Studies , Pulmonary Disease, Chronic Obstructive/epidemiology , Sex Distribution , Smoking/epidemiologyABSTRACT
Environmental tobacco smoke, also called passive smoking, was shown to have adverse effects on the health of children. Hydrogen peroxide (H2O2) is proposed as a sensitive marker of oxidative injury and inflammatory processes in the airways, being increased in adult active cigarette smokers. We tested whether passive smoking had an influence on H2O2 exhalation in healthy children. Thirty healthy passive smoking and 24 nonexposed healthy children aged 9 years were included in the study. Exhaled breath condensate (EBC) was obtained by spontaneous tidal volume breathing with EcoScreen (Jaeger, Germany). All subjects underwent flow-volume measurements immediately after EBC collection. Levels of H2O2 were measured fluorimetrically with the homovanillic acid method. Lung function did not differ between the passive smoking and nonexposed children groups. In the passive smoking group, EBC H2O2 concentration (median and range) was 0.32 (0.00-1.20) microM, and did not differ significantly (P >0.05) from that found in the nonexposed group, i.e., 0,22 (0.00-0.68) microM. Exhaled H2O2 did not correlate with spirometric parameters (FEV1, FEV1%FVC, and MEF50%FVC) in either group. We conclude that passive smoking does not increase H2O2 exhalation in healthy children.
Subject(s)
Environmental Exposure , Hydrogen Peroxide/analysis , Tobacco Smoke Pollution , Biomarkers/analysis , Breath Tests , Child , Female , Humans , Male , Oxidative Stress , Respiratory Function TestsABSTRACT
Clinical efficacy of breath actuated devices depend on value of Peak Inspiratory Flow (PIF), in consequence they are used in older children. Therefore the aim of our study was to assess the ability to use breath actuated inhalers in preschool stable asthmatic children. 156 children aged (mean and 95% CI) 4.5 (95% CI: 4.3-4.6) years participated in the study. Peak Inspiratory Flow Rate (PIFR) assessment with In Check (Clement Clark, U.K.) with resistance valve for Turbuhaler, Diskus, Easi Breathe devices was assessed. Minimal effective value of PIFR significantly frequent for Easi Breathe--98.1% (95% CI 94.5-99.4) compared with Diskus--78.2% (95% CI: 71.1-84.0) and Turbuhaler--71.8% (95% CI 64.3-78.3) (p < 0.05) was found. Significant correlation between PIFR and age of children for all devices was confirmed. We conclude that the use of breath actuated Easi Breathe devices seems to be effective in most preschool asthmatic children in stable period of disease. Use of dry powder inhalers should be preceded by assessments of PIFR with In Check.
Subject(s)
Asthma/drug therapy , Nebulizers and Vaporizers , Aerosols/administration & dosage , Child , Child, Preschool , Confidence Intervals , Equipment Design , Female , Humans , MaleABSTRACT
The evaluation of bronchial hyperreactivity is useful for diagnosis atypical form asthma, in monitoring of anti-inflammatory treatment, in epidemiology and in scientific research. Different stimuli indirect and direct are applied to asses bronchial reactivity. Direct stimuli e.g. methacholine and histamine cause airway limitation by acting on airway smooth muscle. By contrast indirect stimuli (exercise, nonisotonic aerosols, adenosine, mannitol) cause airway limitation by acting inflammatory cells and neuronal cells which release mediators to cause secondary broncho-constriction. Bronchial challenges with direct stimuli are less sensitivity but more specific than the direct challenges in differentiating asthma from normal.
Subject(s)
Asthma/diagnosis , Bronchial Hyperreactivity/diagnosis , Bronchial Provocation Tests/methods , Bronchoconstrictor Agents , Critical Pathways , Forced Expiratory Volume/physiology , Humans , Vital Capacity/physiologyABSTRACT
The evaluation of breath condensate (BC) composition is a new, non-invasive method studying inflammation processes in several respiratory diseases. Among many inflammation markers, hydrogen peroxide (H2O2) is the most common one, and its increased level was found in BC of cystic fibrosis and asthma patients. As in children's asthma, H2O2 is present and could correlates with the severity of the disease. The aim of our study was to check whether there exist differences between levels of H2O2 in children with allergic and non-allergic asthma. 83 allergic and 33 non-allergic children with mild asthma (50 girls and 66 boys, aged 7-17 years) were included in the study. All patients were clinically stable and used inhaled corticosteroids daily, and an inhaled bronchodilator on demand. Exhaled BC was obtained by spontaneously tidal volume breathing with EcoScreen (Jaeger, Germany). The content of H2O2 in the BC was measured spectrofluorometrically (homovanillic acid method). All subjects underwent flow-volume measurements immediately after collection of the condensate. Lung function in asthmatic allergic and non-allergic children showed near normal values and did not differ between groups. In the allergic group, the median H2O2 level in the expired condensate was 0.238 (0-1.86) microM, and in non-allergic 0.192 (0-0.78) microM (p > 0.05). We conclude that hydrogen peroxide in exhaled breath condensate of children with stable mild asthma does not differ significantly in allergic and non-allergic children and activity of airway inflammation seems to independent on allergic status of patients.
Subject(s)
Asthma/classification , Asthma/metabolism , Breath Tests , Hydrogen Peroxide/analysis , Adolescent , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Biomarkers , Child , Exhalation , Female , Forced Expiratory Volume , Glucocorticoids/therapeutic use , Humans , Male , Rhinitis, Allergic, Seasonal/drug therapy , Rhinitis, Allergic, Seasonal/metabolism , Severity of Illness Index , Statistics, NonparametricABSTRACT
Treatment modalities of patients with atopic dermatitis (AD) are dependent on patient age, on the intensity of both skin symptoms and subjective signs of the disease i.e. itch and sleep disturbances, on the body surface involved with lesions, as well as on the type of sensitizing allergens. The characteristic of these allergens is crucial to start prophylaxis and to make decision about specific immunotherapy. In asymptomatic period of the disease the most important factor is to prevent dryness of the skin using emollients, which reconstruct integrity and continuity of stratum corneum. This procedure prevents penetration of air-borne allergens across damaged skin barrier into the skin. In mild AD cases, pimecrolimus (mainly in children) and corticosteroids of the lowest potency alternatively with their basis should be recommended. In moderate intensity AD either topical treatment with calcineurin inhibitors i.e. tacrolimus and pimecrolimus or topical corticosteroids from 4-5 group of American classification should be applied. In addition, PUVA/UVB phototherapy may be beneficial, as well as immunotherapy with specific airborne allergen/s. Coexisting bacterial skin infections should be treated with systemic antibiotics (macrolides, quinolones, and cephalosporins), viral herpes infection systemically using acyclovir for 5-7 days, and fungal infections applying ketoconazole orally, accompanied by topical treatment with miconazole or other antimycotics. Severe AD is an indication for the systemic use of cyclosporin A (rather than corticosteroids), and antibiotics as mentioned above. Prolonged 3-5 year specific immunotherapy is significant concern for selected cases. Sensitive skin areas such as face, orbicular skin, flexures should be treated with pimecrolimus and tacrolimus rather than with corticosteroids, however, topical corticosteroids are recommended on involved skin of the trunk and the extremities besides of flexures. While the improvement of severe AD is reached, the treatment modalities for benign and mild AD should be observed. In all AD patients with active skin lesions antihistaminic drugs of 2nd generation reactive with H1 receptor are a gold standard (or short treatment with these drugs of 1st generation to achieve a sedative effect, followed by the 2nd generation drug), as well as tranquilizers as the combined treatment. There is no reason for the use of anti-leukotriene drugs.
Subject(s)
Allergens/adverse effects , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/therapy , Adolescent , Adult , Age Factors , Aged , Allergens/drug effects , Anti-Allergic Agents/therapeutic use , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Local/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antifungal Agents/therapeutic use , Child , Child, Preschool , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/etiology , Dermatitis, Atopic/prevention & control , Dermatologic Agents/therapeutic use , Disease Progression , Eczema/diagnosis , Eczema/therapy , Enzyme Inhibitors/therapeutic use , Female , Humans , Immunosuppressive Agents/therapeutic use , Infant , Infant, Newborn , Male , Middle Aged , Poland , Practice Guidelines as Topic , Risk FactorsABSTRACT
The introduction of inhaled corticosteroids (ICS) has been a milestone in asthma therapy. According to current guidelines ICS are the first line drug in chronic anti-inflammatory therapy. The purpose of first part of this publication is to present updated knowledge on mechanisms of anti-inflammatory action as well as some pharmacokinetics and pharmacodynamics data about commonly used ICS, especially fluticasone propionate (FP) and two others: budesonide (BUD), beclomethasone dipropionate (BDP). Some differences between mentioned drugs have been found concerning systemic activity and safety of therapy. Fluticasone propionate is twice as active as the BUD and BDP. First results of therapy are seen 1-2 week after administration. Fluticasone propionate, more lipophilic than other steroids, has also high glucocorticoid receptor affinity and specificity, high topical anti-inflammatory activity and low systemic bioavailability. Systemic availability of FP depends on absorption from respiratory system. Oral bioavailability can be neglected because of almost total inactivation in liver during first pass. Fluticasone propionate has some features of dissociated steroids which means predominance of transrepression over transactivation--beneficial from safety point of view. Clinical efficacy of FP in chronic asthma therapy in children was confirmed in many studies. It significantly reduces the symptoms and exacerbations of asthma. There is a close correlation between FP use and lung function tests. The therapy with FP decreases bronchial hyperreactivity and the use of systemic steroids and rescue medication. The beneficial action of fluticasone propionate in asthma is due its anti-inflammatory properties within the airways (decreasing levels of direct and indirect markers of airways inflammations are observed).
Subject(s)
Androstadienes/pharmacology , Anti-Asthmatic Agents/pharmacology , Anti-Inflammatory Agents/pharmacology , Asthma/drug therapy , Glucocorticoids/pharmacology , Administration, Inhalation , Adolescent , Age Factors , Androstadienes/administration & dosage , Androstadienes/adverse effects , Anti-Asthmatic Agents/administration & dosage , Anti-Asthmatic Agents/adverse effects , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/adverse effects , Asthma/prevention & control , Beclomethasone/pharmacology , Biological Availability , Budesonide/pharmacology , Child , Child, Preschool , Drug Administration Schedule , Female , Fluticasone , Glucocorticoids/administration & dosage , Glucocorticoids/adverse effects , Humans , Infant , Infant, Newborn , Male , Peak Expiratory Flow Rate/drug effects , Randomized Controlled Trials as Topic , Treatment OutcomeABSTRACT
Inhaled administration of glucocorticoid doesn't mean lack of systemic effects of drug. Bioavailability of steroid depends on oral absorption and absorption from respiratory system. In case of fluticasone propionate (FP) swallowed dose can be neglected because almost total (>99%) inactivation in liver during first pass. In second part of paper the most important safety parameters of therapy with FP are discussed, it means; influence on hypothalamic-pituitary-adrenal axis, growth and bone metabolism. Interpretation of potential side effects should differentiate between abnormal value of laboratory test and clinically important symptoms. Adrenal suppression depends on dose of FP and was found even after low dose (about 200 microg per day), but clinical value of this findings is unknown. Prolonged administration of high doses can suppress hypothalamic-pituitary-adrenal axis; exceptionally, it can induce adrenal insufficiency. Recommended doses of FP given 1 to 2 years doesn't cause growth retardation. Long term studies on influence of drug on final height are needed. FP as other inhaled corticosteroids, may transiently alter bone metabolism. Till now there are no evidences that this drug, when prescribed appropriately in standard doses for asthma control, may decrease the bone mineral density or induce osteoporosis and may increase the risk of bone fractures in asthmatic children. Effective asthma control achieved with FP therapy permits normal activity and development of asthmatic children which prevails over exceptionally noticed side effects.
Subject(s)
Androstadienes/adverse effects , Anti-Asthmatic Agents/adverse effects , Anti-Inflammatory Agents/adverse effects , Asthma/drug therapy , Hypothalamo-Hypophyseal System/drug effects , Pituitary-Adrenal System/drug effects , Administration, Inhalation , Adolescent , Age Factors , Androstadienes/administration & dosage , Anti-Asthmatic Agents/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Asthma/prevention & control , Bone Density/drug effects , Child , Child, Preschool , Drug Administration Schedule , Female , Fluticasone , Humans , Infant , Infant, Newborn , Male , Osteoporosis/chemically induced , Randomized Controlled Trials as Topic , Risk Factors , Treatment OutcomeABSTRACT
The aim of the study was to assess atopy and its risk factors in school children from Cracow. A survey of atopy in the 223 children, aged 12-14 years, in relation to developmental, environmental and social factors, was conducted in the three districts of Cracow. Atopic sensitization (SPT > 3 mm) was more prevalent in children from highly polluted district of the Stare Miasto than in children living in Prokocim and Nowa Huta (34.7%-26.1%-22.1%). Good and very good socioeconomical status was an important risk factor for development of atopy. Prevalence of atopy was also related to place of residence, living conditions and diseases in early childhood.
Subject(s)
Hypersensitivity, Immediate/epidemiology , Hypersensitivity, Immediate/etiology , Adolescent , Environmental Pollution/adverse effects , Female , Humans , Male , Poland/epidemiology , Prevalence , Risk Factors , Skin Tests , Socioeconomic FactorsABSTRACT
Leptin (LEP) and neuropeptide Y (NPY) are involved in the maintenance of energy balance and create regulatory loops on central and peripheral stage between neuropeptides and hormones, additionally regulated by other physiological stimuli. According to data confirming tendency to overweight and obesity in asthmatic children we have examined the influence of mild asthma on neurohormonal balance. 43 children, aged 7-17 years, including 27 steroid naive mild asthmatic children aged (mean+/-SD) 12.3+/-2.6 years and 16 age matched healthy children participated in the study. Serum LEP and NPY levels were measured radioimmunologically (RIA). Serum leptin level in asthmatic children was 2.84+/-2.1 ng/ml and did not differ to that of healthy children -3.49+/-1.65 ng/ml, both in boys (p=0.85) and girls (0.49). Similarly, we did not observe any differences between NPY levels in asthmatic (113.5+/-31.1 micromol/ml) and healthy (98.5+/-21.9 micromol/ml (p=0.17)), irrespective to sex. Significant correlations between leptin levels and body mass index (BMI) in asthmatics (r=0.62, p=0.01) and healthy children (r=0.56, p=0.02) were observed. We conclude, that mild asthma in children seems not to affect neurohormonal regulation of energy balance.